Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

@article{Malenka2008OutcomesFC,
  title={Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.},
  author={David J. Malenka and Aaron V. Kaplan and Frances Leslie Lucas and Sandra Sharp and Jonathan S. Skinner},
  journal={JAMA},
  year={2008},
  volume={299 24},
  pages={
          2868-76
        }
}

• David J. Malenka, Aaron V. Kaplan, +2 authors Jonathan S. Skinner
• Published 2008 in JAMA
• DOI:10.1001/jama.299.24.2868

CONTEXT Although drug-eluting stents reduce restenosis rates relative to bare-metal stents, concerns have been raised that drug-eluting stents may also be associated with an increased risk of stent thrombosis. Our study focused on the effect of stent type on population-based interventional outcomes. OBJECTIVE To compare outcomes of Medicare beneficiaries who underwent nonemergent coronary stenting before and after the availability of drug-eluting stents. DESIGN, SETTING, AND PATIENTS… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed